VBI VACCINES INC

YTD

ALL

Why Robinhood?

You can watch VBIVQ and buy or sell other stocks, ETFs, and their options commission-free!

About VBIVQ

VBI Vaccines, Inc. is a biopharmaceutical company, which engages in the development of infectious disease and immuno-oncology vaccines. The firm focuses on the prevention and treatment of hepatitis B through its product pipeline, Sci-B-Vac and VBI-2601.

CEO

Jeff Baxter

CEOJeff Baxter

Employees

—

Employees—

Headquarters

Cambridge, Massachusetts

HeadquartersCambridge, Massachusetts

Founded

1965

Founded1965

Employees

—

Employees—

VBIVQ Key Statistics

Market cap

14.30K

Market cap14.30K

Price-Earnings ratio

—

Price-Earnings ratio—

Dividend yield

—

Dividend yield—

Average volume

30.72K

Average volume30.72K

High today

—

High today—

Low today

—

Low today—

Open price

—

Open price—

Volume

0.00

Volume0.00

52 Week high

$0.0505

52 Week high$0.0505

52 Week low

—

52 Week low—

Stock Snapshot

As of today, VBI VACCINES INC(VBIVQ) shares are valued at $0.00. The company's market cap stands at 14.3K.

VBI VACCINES INC(VBIVQ) stock opened on 2025-12-10 at —. The price climbed to — and dipped to —.

VBI VACCINES INC(VBIVQ) shares are trading with a volume of 0, against a daily average of 30.72K.

People also own

Based on the portfolios of people who own VBIVQ. This list is generated using Robinhood data, and it’s not a recommendation.